Kochi: The largest cleft focused NGO in India, Smile Train and Simulare Medical, leading innovators in surgical simulators, are organizing a breakthrough simulator training for medical professionals at the upcoming Indo-Cleft Con – 2022, to be held on May 19 in Kochi, Kerala, where the first-of-its-kind Cleft Lip and Palate Simulators will be made available to the Indian healthcare fraternity. This innovation in high fidelity cleft surgical simulators from Simulare Medical showcases the potential of such tools and technologies in facilitating surgical training and will greatly support cost-effective and scalable training models in India.
With Simulare, surgeons have access to hyper-realistic 3D-printed models where they can learn and hone their surgical skills outside the OT. Its silicone components mimic the oral soft tissues of young children, providing the most accurate recreation of patient conditions. Simulare utilises a range of silicones to replicate different kinds of tissue like skin, muscle and fat, with all its models being manufactured and hand-assembled at their facility in Canada.
Talking about the innovative training resource, Smile Train’s Senior Vice President and Regional Director for Asia said, “In many low-resource regions, safe, high-quality surgical training can be a challenge, particularly for specialty treatment such as cleft lip and palate. We hope to leverage this technology to offer additional training to surgeons around the world providing lifesaving treatment to those in need. This latest innovation advances our vision of providing care for every cleft-affected person and demonstrates our commitment to leveraging technology to further education and change lives.”
The one day ‘Train the Trainer’ Workshop for senior plastic and maxillofacial surgeons will undertake two surgeries – using lip and palate simulators. After this training, these senior surgeons will conduct simulator training across India – hereby providing young surgeons a live surgery experience with simulators.
(India CSR)
